RaySearch Laboratories (SE)
RaySearch Laboratories AB is a Swedish medical technology company focused on developing software solutions for radiation therapy in cancer treatment. The company produces the RayStation treatment planning system and the RayCare oncology information system, providing advanced algorithm optimization for external beam radiation and proton therapy. Principal revenue streams are derived from software license sales, annual software maintenance agreements, and clinical consulting support. RaySearch Laboratories serves university hospitals, cancer clinics, radiotherapy research centers, and oncology centers globally. The enterprise holds a leading international market position in advanced software systems for radiation treatment planning. RaySearch Laboratories AB is headquartered in Stockholm, Sweden, and its Class B shares are listed on Nasdaq Stockholm.
16 of the funds FundTelligence covers report a position in RaySearch Laboratories (SE).
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 16
Funds holding RaySearch Laboratories (SE)
- Case All Star Småbolag — Case · 5.72 % (full portfolio disclosed, June 2026)
- Case Gaia Microcap — Case · 5.02 % (full portfolio disclosed, June 2026)
- TIN Ny Teknik — Tin Fonder · 3.53 % (full portfolio disclosed, June 2026)
- Schroder ISF Nordic Micro Cap — Schroders · 3.34 % (full portfolio disclosed, June 2026)
- Aktiespararna Småbolag Edge — Cicero Fonder · 2.34 % (full portfolio disclosed, June 2026)
- DNB Fund Nordic Small Cap — DNB · 1.59 % (full portfolio disclosed, September 2026)
- Handelsbanken Microcap Norden — Handelsbanken · 0.99 % (full portfolio disclosed, October 2026)
- Swedbank Robur Healthcare — Swedbank · 0.28 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 16 funds holding it.